TLP
AVDL
Tri Locum Partners’s Avadel Pharmaceuticals AVDL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.98M | Buy |
+1,014,456
| New | +$8.98M | 2.72% | 14 |
|
|
2025
Q1 | – | Sell |
-1,937,984
| Closed | -$20.4M | – | 23 |
|
|
2024
Q4 | $20.4M | Buy |
1,937,984
+277,029
| +17% | +$2.91M | 4.22% | 9 |
|
|
2024
Q3 | $21.8M | Buy |
1,660,955
+471,437
| +40% | +$6.18M | 5.22% | 8 |
|
|
2024
Q2 | $16.7M | Buy |
1,189,518
+7
| +0% | +$98 | 4.23% | 12 |
|
|
2024
Q1 | $20.1M | Buy |
1,189,511
+349,578
| +42% | +$5.9M | 6.97% | 2 |
|
|
2023
Q4 | $11.9M | Sell |
839,933
-143,669
| -15% | -$2.03M | 5.42% | 6 |
|
|
2023
Q3 | $10.1M | Sell |
983,602
-55,872
| -5% | -$575K | 3.24% | 9 |
|
|
2023
Q2 | $17.1M | Sell |
1,039,474
-287,623
| -22% | -$4.74M | 6.37% | 3 |
|
|
2023
Q1 | $12.2M | Buy |
1,327,097
+642,541
| +94% | +$5.89M | 3.7% | 10 |
|
|
2022
Q4 | $4.9M | Buy |
+684,556
| New | +$4.9M | 1.98% | 18 |
|
|
2021
Q4 | – | Sell |
-148,355
| Closed | -$1.45M | – | 39 |
|
|
2021
Q3 | $1.45M | Sell |
148,355
-165,440
| -53% | -$1.62M | 0.58% | 21 |
|
|
2021
Q2 | $2.11M | Buy |
313,795
+153,539
| +96% | +$1.03M | 0.69% | 20 |
|
|
2021
Q1 | $1.45M | Buy |
+160,256
| New | +$1.45M | 0.36% | 26 |
|